TETRA Technologies, Inc. (TTI) News
Follow TETRA Technologies, Inc. (TTI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 16 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Tetra Technologies Q3 Earnings Snapshot
EQUITY | Nov 03, 2026, 04:31 AM UTC
M
TETRA Technologies Reports Quarterly Results Through September 30
EQUITY | Nov 02, 2026, 11:39 PM UTC
M
Tetra Technologies Reports Third-Quarter Revenue of $168M
EQUITY | Nov 02, 2026, 10:13 PM UTC
L
Tetra Technologies Reports Q3 EPS of $0.05
EARNINGS | Nov 02, 2026, 10:11 PM UTC
M
TETRA Technologies Posts Q3 Adjusted EPS of $0.06 Per Share
TETRA Technologies reported Q3 adjusted EPS of $0.06, versus the FactSet estimate of $0.05.
EARNINGS | Nov 02, 2026, 10:05 PM UTC
M
Tetra Technologies Q3 Adjusted EPS $0.06 vs. IBES Estimate $0.04
Tetra Technologies reported Q3 adjusted EPS of $0.06, compared with the IBES estimate of $0.04.
EARNINGS | Nov 02, 2026, 10:01 PM UTC
M
Tetra Technologies Reports Q3 Gross Profit of $35.097 Million
EQUITY | Nov 02, 2026, 10:01 PM UTC
M
Tetra Technologies Q3 Adjusted EBITDA $25.115 Million
EARNINGS | Nov 02, 2026, 10:01 PM UTC
L
Tetra Technologies Is Maintained at Buy by Stifel
Ratings actions from Benzinga: GMT) Tetra Technologies Price Target Cut to $12.00/Share From $13.00 by StifelRatings actions from Benzinga
NEWS | Sep 23, 2026, 05:11 PM UTC
L
Stifel maintains Buy rating on Tetra Technologies, $12 price target
Stifel maintained their Buy rating on Tetra Technologies's stock with a price target of $12.00.The price target implies an upside of 99.3% from the Sep 22 close of $6.02.Key takeaways from the analyst noteStrong Growth P
EQUITY | Sep 23, 2026, 05:01 PM UTC
M
Thiogenesis reports 2026 annual and special meeting results
Thiogenesis Therapeutics announced results of its 2026 annual and special meeting of shareholders and provided a corporate update.
EQUITY | Sep 21, 2026, 08:01 AM UTC
L
Thiogenesis hires Brisco Capital for investor relations
Thiogenesis Therapeutics said it has engaged Brisco Capital for investor relations. The company is a clinical-stage biotech developing sulfur-based therapeutics for rare diseases.
EQUITY | Sep 03, 2026, 10:06 AM UTC
L
TTI - TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
TTI - TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
EQUITY | Sep 02, 2026, 05:49 PM UTC
L
TTI - TETRA TECHNOLOGIES, INC. REPORTS STRONG SECOND-QUARTER 2026 RESULTS
TTI - TETRA TECHNOLOGIES, INC. REPORTS STRONG SECOND-QUARTER 2026 RESULTS
EQUITY | Aug 03, 2026, 09:58 PM UTC
L
Tetra Technologies Insider Sold Shares Worth $536,745, According to a Recent SEC Filing
() -- Brady M Murphy, President & CEO, on July 01, 2026, sold 50,061 shares in Tetra Technologies (TTI) for $536,745. Following the Form 4 filing with the SEC, Murphy has control over a total of 2,965,396 common shares o
GEOPOLITICS | Jul 02, 2026, 09:07 PM UTC
L
Northland Capital Markets Maintains Outperform on Tetra Technologies, Raises Price Target to $14
Northland Capital Markets analyst Bobby Brooks maintains Tetra Technologies (NYSE: TTI ) with a Outperform and raises the price target from $11.5 to $14.
EQUITY | Jun 30, 2026, 05:04 PM UTC